Study of Effect the Purified Protease Enzyme with Antibiotics on Pathogenic P. Aeruginosa in-vitro and in-vivo
DOI:
https://doi.org/10.22317/imj.v8i3.1290Keywords:
Pseudomonas aeruginosa, Anti-Bacterial Agents, Peptide Hydrolases.Abstract
Objective: The goal of this study is the detection of the P. aeruginosa isolate for production the protease, the optimal conditions for produce, extraction, purification and characterization of the enzyme and study the synergistic effect of protease with antibiotics on P. aeruginosa.
Method: Among (110) isolates from clinical sources, only (74) isolates identified as P. aeruginosa isolated from Baghdad hospitals. Detection of the optimal isolate for production the protease enzyme and the optimal conditions its produce, purification of enzyme by using ammonium sulfate, ion exchange chromatography and gel filtration, enzyme characterization of PH and temperature activity and stability, the study of synergistic effect of protease with antibiotics on P. aeruginosa.
Result: The optimal conditions to produce protease is pH (8), (37) ºC, (BHI) broth, and during (48 hrs.). The precipitation saturation ratio (80%). Ion- exchanges (DEAE and CM) Cellulose and Gel filtration have specific activity ((121.25), (161.6), (660.53)) units/ mg)) respectively. The characterization done by pH and temperature activity purified protease was active in (138.51units/ ml) at pH (8), and stable in pH (8), the temperature for protease activity is (158.21 units/ ml) at (37) ºC. The synergistic effect of purified protease with antibiotics on P. aeruginosa in- vitro, was detected using the agar diffusion method, the effectiveness of the prepared hydrogel types, the results showed P. aeruginosa was sensitive isolate to prepare (Gel & Protease & Ceftriaxone) the diameter of the inhibition zone reached (42 mm), the synergistic effect we noticed when using a (Gel & Ceftriaxone & Protease) healing was observed in time (7-10 days) with wound healing without effect.
Conclusion: In this study, it was discovered that mixing (protease + hydrogel + Ceftriaxone) accelerates the wound healing without leaving traces.
References
- Ali, A. M; Al-Kenanei, K. A; and Bdaiwi, Q. O. (2020). Molecular study of some
virulence genes of Pseudomonas aeruginosa isolated from different
in hospitals of Bagh. Rev. Res. Med. Microbiol, 31(1), 26-41.
- Horna, G; and Ruiz, J. (2021). Type 3 secretion system of Pseudomonas
aeruginosa. Microbiol Res, 246, 126719.
- Neethu, S. K.; Sreeja Devi, P. S.; & Arun, S. N. (2016). A review on
microbial proteases. Int J Adv Res, 4(7), 2048-2053
- Sun, J., LaRock, D. L., Skowronski, E. A., Kimmey, J. M., Olson, J., Jiang, Z.,
... & LaRock, C. N. (2020). The Pseudomonas aeruginosa protease LasB
directly activates IL-1β. EBioMedicine, 60.
- Senior, B.W. (1999). Investigation of the types and characteristics of the proteolytic enzyme formed by diverse strains of proteus species. J. Med. Microbial. 48: 623 -628.
- Jian, L.; Mahnaz, R.; Stephanie, F.; Clare, C.; Jae, M.; Masanobu, S.;
Alkis, P.; Peter, J, W; Sarah, V. (2019). Pseudomonas aeruginosa
Exoprotein-Induced Barrier Disruption Correlates with Elastase Activity
and Marks Chronic Rhinosinusitis Severity. Front. Cell. Infect. Microbiol. 123: 293–302.
- Barequet, I. S., Ben Simon, G. J., Safrin, M., Ohman, D. E., & Kessler, E. (2004). Pseudomonas aeruginosa LasA protease in treatment of experimental staphylococcal keratitis. Antimicrobial agents and chemotherapy, 48(5), 1681-1687.
- Coin, D.; Louis, D.; Bernillon, J.; Guinand, M. and Wallach, J. (1997). Las A, Alkaline protease and elastase in clinical strains of Pseudomonas aeruginosa: quantification by immunochemical methods. FEMS Immunology and Medical Microbiology. 18 :175-184.
- Hussein, H. A. (2016). Production and purification of protease from mutant Pseudomonas aeruginosa isolated from clinical samples. M. Sc. Thesis. College of biotechnology, University of Al-Nahrain, Iraq.
- Hamdan, N. T.; & Jasim, H. M. (2018). Purification and characterization of cellulase enzyme from Trichoderma longibrachiatum isolated in Iraqi soil. J Biotechnol Biochem, 4(1), 32-41.
- Andrews, P. (1964). Estimation of the molecular weights of proteins by Sephadex gel-filtration. Biochemical Journal, 91(2), 222.
- Dasilva, O. S.; Gomes, M. H. G.; de Oliveira, R. L.; Porto, A. L. F.;
Converti, A.; & Porto, T. S. (2017). Partitioning and extraction protease from Aspergillus tamarii URM4634 using PEG-citrate aqueous two-phase systems. Biocatalysis and Agricultural Biotechnology, 9, 168-173.
- Peters , J. E. and Galloway , D. R. (1990) . Purification and Characterization of an active fragment of the Las A protein from Pseudomonas aeruginosa : Enhancement of Elastase activity . Journal of Bacteriology . 172 (5) : 2236-2240 .
- Shanmugasundaram, O. L., and Gowda, R.M. (2012). Development and characterization of cotton, organic cotton flat knit fabrics coated with chitosan, sodium alginate, calcium alginate polymers, and antibiotic drugs for wound healing. Journal of Industrial Textiles, 42(2), 156-175.
- Elshikh, M., Ahmed, S., Funston, S., Dunlop, P., McGaw, M., Marchant, R., & Banat, I. M. (2016). Resazurin-based 96-well plate microdilution method for the determination of minimum inhibitory concentration of biosurfactants. Biotechnology Letters, 38(6), 1015–1019.
- Ali, O.A. (2012). Prevention of Proteus mirabilis biofilm surfactant solution. Egypt. Acad.J. Bioloy. Sci., 4(1) :1-8.
- Panáček, A., Smékalová, M., Kilianová, M., Prucek,R., Bogdanová, K., Veˇceˇrová ,R., Kolář, M.,Havrdová, M.,…, Kvítek,L. (2016). Strong and Nonspecific Synergistic Antibacterial Efficiency of Antibiotics Combined with Silver Nanoparticles at Very Low Concentrations Showing No Cytotoxic Effect.Molecules, 21, 26.
- Ahmed .T.Jabar.(2020).The effect of Pyocyanin produced by peudimonas aeruginosa against some pathogenic bacteria and their biofilm productor. M.S.C thesis inAlmustansiriyah university.
- Doern, C. D., 2014. When does 2 plus 2 equal 5 A review of antimicrobial synergy testing. J. Clin. Microbiol. 52(12), 4124-4128.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Iraq Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.